Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve (1) Migration of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudarshan Pharma Industries Ltd has scheduled a Board meeting on 22nd May 2026 to consider migrating its equity shares from the BSE SME Platform to the Main Board of BSE Limited. The company also plans to apply for listing on the Main Board of NSE (National Stock Exchange of India). These proposals are subject to shareholder approval, which will be sought via a Postal Ballot. The migration signifies the company's growth and readiness to move to a larger, more prominent exchange platform typically followed by a wider investor base.
Migration to Main Board from SME Platform is generally a positive signal — it reflects improved scale, governance, and liquidity. Shareholders may benefit from wider market visibility, better trading volumes, and potential re-rating of the stock.